Riluzole, a drug in use for the treatment of Lateral Amyotrophic Sclerosis, was repurposed for AD as it increases glutamate uptake via several glutamate transporters (GLT-1, GLAST, EAAC1) [87]. Here, SLC1A2 is linked to Alzheimer disease.